selection and model averaging. To clarify the role of CCR5 host genetic background and disease 48 progression on viral evolutionary patterns, we obtain gp120 envelope sequences from clonal 49
HIV-1 variants isolated at multiple time points in the course of infection from populations of 50
HIV-1 infected individuals who only harbored CCR5-using HIV-1 variants at all time points. 51
Presence or absence of a CCR5 wt/Δ32 genotype and progressive or long-term non-progressive 52 course of infection stratify the clinical populations in a two-way design. As compared to the 53 standard approach of analyzing sequences from each patient independently, the HPM provides 54 more efficient estimation of evolutionary parameters such as nucleotide substitution rates and 55 d N /d S rate ratios, as shown by significant shrinkage of the estimator variance. The fixed-effects 56 also corrects for non-independence of data between populations and results in even further 57 shrinkage of individual patient estimates. Model selection suggests an association between 58 nucleotide substitution rate and disease progression, but a role for CCR5 genotype remains 59 elusive. Given the absence of clear d N /d S differences between patient groups, delayed onset of 60 AIDS symptoms appears to be solely associated with lower viral replication rates rather than with 61 differences in selection on amino acid fixation. 62
63

INTRODUCTION 63
The high mutation rate and rapid viral turnover that characterize HIV-1 infection (Ho et al. 1995; 9 and expanded to viral stocks for further study as described previously (Schuitemaker et al. 1992 ; 164 van 't Wout, Schuitemaker, and Kootstra 2008) . For each patient, time points of virus isolation 165 and number of clonal HIV-1 variants per time point are summarized in Supplementary Table S1 . 166 The R5 phenotype of all clonal HIV-1 variants that were isolated was confirmed by inability to 167 replicate in the MT2 cell-line, in PHA-PBMC from a donor with a CCR5∆32 homozygous 168 genotype and in astroglioma cells transfected with CD4 and CCR3 or CXCR4 (de Roda Husman 169 et al. 1999b) and predicted co-receptor use based on the V3 amino acid sequence using the 170 position specific scoring matrix (PSSM) NSI/SI 171 (http://indra.mullins.microbiol.washington.edu/pssm/ ) (Jensen et al. 2003) . 172
173
DNA isolation, PCR and sequencing 174
Total DNA was isolated from PBMCs infected with clonal HIV-1 variants using a modification 175 of the L6 isolation method (Kootstra and Schuitemaker 1999) . Precipitated DNA was dissolved 176 in 100µl of distilled water and 5µl were used for PCR amplification of the gp120 (C1-C4) region 177 corresponding to HXB2 nucleotide positions 6444 to 7595. Amplification was performed by PCR 178 with primers TB3 forward (5'-GGCCTTATTAGGACACATAGTTAGCC-3') and OFM19 179 reverse (5'-GCACTCAAGGCAAGCTTTATTGAGGCTTA-3') using the expand high fidelity 180
Taq polymerase kit (Roche) and the following amplification cycles: 2 min 30s 94˚C, 9 cycles of 181 15s 94˚C, 45s 50˚C, 6 min 68˚C, 30 cycles of 15s 94˚C, 45s 53˚C, 6 min 68˚C, followed by a 10 182 min extension at 68˚C and subsequent cooling to 4˚C. Nested Bayesian mixed effects model that pools information across patients. Pooling information 220 through random effects affords more precise individual-patient parameter estimates when the data 221 are sparse for a patient. Further, unique to the work here, the introduction of fixed effects (see 222 below) offers a formal hypothesis testing framework from which to identify differences in 223 evolutionary process between patient population groups. For nucleotide analyses, we apply this hierarchical setup to the strict clock evolutionary rate (on 238 the log-scale), the mean evolutionary rate parameter of the lognormal relaxed clock (log), the 239 constant population size (log) of the demographic prior, the GTR substitution parameters (log) 240 and the shape parameter (log) of the discrete gamma distribution modeling rate variation among 241 Bayesian stochastic search variable selection in further detail (Lemey et al. 2009 ). 260
We complete this HPM model with variable selection through assigning independent Bernoulli 261 prior probability distributions on δ LTNP and δΔ 32 . These distributions place equal probability on 262 each factor's inclusion and exclusion. We further assume diffuse priors on the unknown grand-263 mean and error variance and specify that a priori β LTNP and βΔ 32 are normally distributed with 264 mean 0 and a variance of 1/2. We choose 1/2 as, before seeing the data, we believe that, if a 265 factor does result in different evolutionary parameters across population groups, process The posterior odds follow immediately from the marginal posterior probability that a factor 284 indicator equals 1 that we estimate through the posterior expectation of the factor indicator. In 285 cases where an estimate of this expectation approaches very closely to 0 or 1, an estimator based 286 on a Rao-Blackwellization procedure is available (Casella and Robert 1996). 287
288
RESULTS
288
Independent versus hierarchical estimation of evolutionary parameters 289
We first explored the nucleotide substitution rate as a hierarchical parameter estimated across 290 patients in four separate patient groups: Progressors, LTNP, CCR5 wt/wt and CCR5 wt/Δ32. 291
Using a strict clock model, a higher mean evolutionary rate was estimated in the Progressors 292 group (mean = 7. Figure 2B ), in which the log of the mean evolutionary rate across all branches in a patient 301 genealogy is drawn from an underlying normal distribution. For both strict and relaxed 302 evolutionary rate estimates (Figure 3 A and B) , as well as other substitution model and 303 population genetic parameters (data not shown), we observed significant shrinkage in uncertainty 304 under the standard hierarchical fit, which clearly demonstrates the HPM improvement. Moreover, 305 separate fit of parameter-rich models such as the uncorrelated relaxed clock required informative 306 priors to achieve efficient sampling. To demonstrate the impact of such priors on our posterior 307 rate estimates obtained by separate model fitting, and compare these with the hierarchical 308 estimates that did not require such priors, we plot the marginal posterior rate estimates for the 309 three least informative (lowest number of time points and/or sequences per time point) and three 310 most informative patients within the LTNP group (P10, P16 and P17 versus P9, P11 and P13 311 respectively) as violin plots in Figure 4 . Violin plots are box plots overlaid with (rotated) kernel 312 density estimates in order to show to the probability density at different parameter values. The 313 patients for which only two or three time points were available resulted in rate estimates that only 314 weakly diverged from their respective prior (uniform[0,0.004] or lognormal(-7.5,1); Figure 4A  315 and C respectively), whereas many time points provide sufficient information to dominate over 316 these priors (Figure 4 B and D) . Under the hierarchical model, even weakly informative patient-317 specific data sets with extremely diffuse priors on the rate yield relative precise posteriors ( Figure  318 4E), and the individual patient estimates are only marginally higher than for the three most 319 informative patients ( Figure 4F ). This demonstrates that comparing the mean rates for individual 320 estimates would is inappropriate to assess differences among patient groups. Weakly informative 321 patients result in relatively high mean rates, but their high variances ensure that the contribution 322 to the population rate (LTNP group) in the hierarchical model remains low. 323
While the application of relaxed clock models to individual data sets with few time points or 324 sequences may be questionable, analysis under a HPM, in which information is pooled between 325 patients, enables us to side-step this limitation. Marginal likelihood estimates for the both strict 326 and relaxed clock analyses of the different patient groups (Supplementary Table S2) Figure 1B) . 337 338
Hypothesis testing using HPMs incorporating across-population fixed effects 339
The four different groups considered previously are not comprised of independent patient sets; 340 some patients fall in more than one group. Hence, direct comparison of the marginal parameter 341 estimates fit to each group independently does not generate independent estimates. For more 342 appropriate hypothesis testing of difference, the HPM for the evolutionary rate was extended to In this study, we adopted a HPM approach to estimate within-host HIV evolutionary parameters 369 and test evolutionary hypotheses regarding host susceptibility and disease progression. We 370 sought to investigate whether the CCR5 wt/∆32 genotype, which is associated with a lower viral 371 load set point and a slower HIV-1 disease progression ( 2002) arising from the independent prior specifications on the other hand. The HPM sits in 386 between these two extremes and reduces the effective number of parameters without sacrificing 387 fit to the data. Furthermore, we demonstrate that the HPM is more powerful in rejecting simpler 388 evolutionary models, like the constant rate assumption, which is frequently violated for HIV. 389
The hierarchical estimates for the Progressors, LTNP, CCR5 wt/wt and CCR5 wt/Δ32 groups 390 indicated a pronounced strict and relaxed clock rate difference between the Progressors and 391 20 LTNP, whereas differences between CCR5 wt/wt and CCR5 wt/Δ32 rates were less pronounced. 392
The same patterns were observed for relaxed codon substitution rates, but no real differences 393 were noted in terms of d N /d S . These comparisons are based on non-independent data because 394 patients will be part of two different groups. For more appropriate hypothesis testing, we 395 incorporated fixed effects and employed Bayesian stochastic search variable selection to estimate 396 the posterior probability that different patient group characteristics influence within-host 397 evolutionary parameters. The advantage of a Bayesian model averaging approach that 398 simultaneously explores the space of models and regression coefficients is the opportunity to 399 distinguish between the relative size of an effect and its importance, which can be formalized in 400 terms of standard Bayes factor support. The latter effectively becomes independent of the scale of 401 the predictors, which otherwise may confound drawing conclusions on the effect sizes only. 402
Because both predictors we considered only achieve 0 or 1, controlling for scale is not an issue in 403 the current study, but it does contribute to a more general framework for evolutionary hypothesis 404 testing. While the statistical support is not decisive, the fixed-effects HPM approach produces 405 substantially more efficient parameter estimates and conditional effect sizes confirm rate 406 differences among LTNP and Progressors. Despite the elevated power, more elaborate sampling 407 in terms of numbers of patients, within-host time points or maybe even larger genome regions 408 would be desirable. 409
The HPM estimates suggest an association between evolutionary rate and disease progression, 410 but the CCR5 genotype does not account for the rate differences. Given the absence of clear 411 d N /d S differences -if anything, they are slightly higher in LTNP -we cannot attribute the rate 412 nuances to differences in selection on amino acid fixation. Therefore, we conclude that these 413 differences are due to variations in the product of mutation rate and generation time. being violated when considering HIV evolution. Parameter-rich models may be limited by 453 current sampling as they require highly informative data. To our knowledge, the most elaborate 454 sampling dates back to over a decade ago (Shankarappa et al. 1999 ), which, differently from this 455 study, included patients with HIV populations harboring CXCR4-using variants. Next generation 456 sequencing may offer new opportunities for within host HIV genetic analyses, but produces data 457 with particular challenges for comparative analyses (Vrancken et al. 2010 ). Here, we have 458 adopted a modeling approach that efficiently pools the information from multiple individuals and 459 we demonstrate how this can be employed for rigorous testing across patient populations. We 460 hope that this stimulates further model-based inference of evolutionary processes, which 461 ultimately may lead to more profound insights into persistent viral infections. 
